Treatment of Langerhans cell histiocytosis bone lesions with zoledronic acid: A case series

International Journal of Hematology

Volumn 93, Issue 6, 2011, Pages 782-786

  Sivendran, Shanthi ^a   Harvey, Harold ^a   Lipton, Allan ^a   Drabick, Joseph ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Bisphosphonates; Langerhans cell histiocytosis; Zolendronic acid

Indexed keywords

PROTEIN S 100; T6 ANTIGEN; ZOLEDRONIC ACID;

ADULT; ANAMNESIS; ARTICLE; ASPIRATION BIOPSY; BONE BIOPSY; BONE SCINTISCANNING; CANCER INHIBITION; CASE REPORT; CURETTAGE; FEMALE; HIP PAIN; HISTIOCYTOSIS X; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; RADIOGRAPHY; TUMOR VOLUME;

ADULT; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES; DIPHOSPHONATES; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMIDAZOLES; MALE; PAIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960107657     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0839-2     Document Type: Article

References (17)

1. A Coppes-Zantinga RM Egeler 2002 The Langerhans cell histiocytosis X files revealed Br J Haematol 116 3 9 (Pubitemid 34122058)
2. GI Bechan RM Egeler RJ Arceci 2006 Biology of Langerhans cells and Langerhans cell histiocytosis Int Rev Cytol 254 1 43 (Pubitemid 44828726)
3. EM Azouz G Saigal MM Rodriguez A Podda 2005 Langerhans' cell histiocytosis: pathology, imaging and treatment of skeletal involvement Pediatr Radiol 35 103 115 (Pubitemid 40124562)
4. B Willis A Ablin V Weinberg S Zoger WM Wara KK Matthay 1996 Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco J Clin Oncol 14 2073 2082 (Pubitemid 26230109)
5. RP Farran E Zaretski RM Egeler 2001 Treatment of Langerhans cell histiocytosis with pamidronate J Pediatr Hematol Oncol 23 54 56 (Pubitemid 32124986)
6. A Morimoto S Ikushima N Kinugawa 2006 Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study Cancer 107 613 619 (Pubitemid 44107223)
7. H Gadner N Grois U Potschger 2008 Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification Blood 111 2556 2562
8. T Imamura T Sato Y Shiota 2010 Outcome of pediatric patients with Langerhans cell histiocytosis treated with 2 chlorodeoxyadenosine: a nationwide survey in Japan Int J Hematol 91 646 651
9. JR Gralow JS Biermann A Farooki 2009 NCCN Task Force Report: bone health in cancer care J Natl Compr Canc Netw 7 Suppl 3 S1 S32 (quiz S3-S5)
10. H Fleisch 1998 Bisphosphonates: mechanisms of action Endocr Rev 19 80 100 (Pubitemid 29122075)
11. J Kamizono Y Okada A Shirahata Y Tanaka 2002 Bisphosphonate induces remission of refractory osteolysis in langerhans cell histiocytosis J Bone Miner Res 17 1926 1928 (Pubitemid 35239191)
12. K Arzoo S Sadeghi V Pullarkat 2001 Pamidronate for bone pain from osteolytic lesions in Langerhans'-cell histiocytosis N Engl J Med 345 225 (Pubitemid 32662141)
13. L Montella C Merola G Merola L Petillo G Palmieri 2009 Zoledronic acid in treatment of bone lesions by Langerhans cell histiocytosis J Bone Miner Metab 27 110 113
14. I Elomaa C Blomqvist L Porkka T Holmstrom 1989 Experiences of clodronate treatment of multifocal eosinophilic granuloma of bone J Intern Med 225 59 61 (Pubitemid 19118691)
15. JR Green 2004 Bisphosphonates: preclinical review Oncologist 9 Suppl 4 3 13 (Pubitemid 39363164)
16. RE Brown 2001 More on pamidronate in Langerhans'-cell histiocytosis N Engl J Med 345 1503
17. RE Coleman 2004 Bisphosphonates: clinical experience Oncologist 9 Suppl 4 14 27 (Pubitemid 39363165)